Review · Kato et al., Frontiers in Immunology (2025)
LC-Plasma: pDC markers and cold-like symptoms in healthy adults(opens in a new tab)
- Findings and study population
- Meta-analysis of eight RCTs (100 billion cells/day, 13–84 days, 619 pDC and 555 symptom participants) showed fewer cough (-0.69 days/28 days) and feverishness (-0.26 days) days.
- Limitations and differences from this claim
- Confirmed-infection prevention was not established. Cough analyses had high bias risk from exclusions. Kirin funded all trials and the meta-analysis; the latter includes employee authors.
Checked: